Average Co-Inventor Count = 3.37
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (29 from 1,179 patents)
2. Hitec Co., Ltd. (17 from 39 patents)
3. Sony Corporation (6 from 58,132 patents)
4. Kyoueisenzai Kabushikigaisha (3 from 3 patents)
5. Nippon Steel Corporation (2 from 3,568 patents)
6. Mitsubishi Denki Kabushiki Kaisha (1 from 21,351 patents)
7. Mitsubishi Electric Corporation (1 from 15,942 patents)
8. Olympus Medical Systems Corporation (1 from 1,164 patents)
9. Toyo Ink Manufacturing Company (1 from 223 patents)
10. Toyo Ink Mfg. Co., Ltd. (1 from 105 patents)
11. Toray Engineering Company, Limited (1 from 105 patents)
12. Mitaka Kohki Co., Ltd. (1 from 66 patents)
13. Fukutome Meat Packers, Ltd. (1 from 2 patents)
14. Hitech Co. Ltd. (1 from 1 patent)
65 patents:
1. 11834409 - Heterocyclic NMDA antagonists
2. 11702419 - Heterocyclic compound and use thereof
3. 11459325 - Heterocyclic compound
4. 11274101 - Heterocyclic compound
5. 10899752 - 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
6. 10865200 - Nitrogen-containing heterocyclic compound
7. 10807987 - Heterocyclic compound and use thereof
8. 10610520 - Heterocyclic compound
9. 10548899 - Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
10. 10514996 - Simulation reproducing apparatus and computer-readable recording medium
11. 10457670 - Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease
12. 10428056 - Heterocyclic compound
13. 10323027 - 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
14. 10323026 - Heterocyclic compound
15. 10208046 - Nitrogen-containing heterocyclic compound